Generative AI-Powered Business Process Tools for Drug Development Programs: Some Implementation Examples

Music City Center 

With generative AI setting in motion upon the release of OpenAI's GPT3 in 2000 and ChatGPT in 2022, researchers from cross-disciplines have been actively seeking innovative applications of generative AI tools such as large language models (LLMs) across industries. Such exploratory efforts gradually propagate to clinical development applications, though wide applications in production are still relatively few. On the one hand, LLM research is blooming. On the other hand, many clinical trialists are still seeking good use cases and jumping through hurdles to implement LLM tools in production environment. In this talk, I will share some examples of generative AI initiatives in drug development process and discuss statistician's role in these projects.

generative AI

artificial intelligence

drug development

clinical trial